Ingenza partners with HydRegen to advance sustainable biomanufacturing

No­var­tis is ax­ing 103 em­ploy­ees in New Jer­sey across clin­i­cal op­er­a­tions, call­ing the cuts part of an “or­ga­ni­za­tion­al evo­lu­tion.” The lay­offs will af­fect em­ploy­ees in

In June, Abeona pushed back the time­line for its ap­pli­ca­tion to the FDA for ap­proval of a rare ge­net­ic skin cell ther­a­py. At the time,

Will Ver­tex’s “pipeline-in-a-prod­uct” pay off? That’s the bet be­hind the com­pa­ny’s $4.9 bil­lion ac­qui­si­tion of Alpine Im­mune Sci­ences and its mid-stage IgA nephropa­thy drug, which